BRCA2 and breast cancer: We identified a total of 308 potentially relevant studies that described the association between certain polymorphic repeat length in the AIB1 gene and BC risk in BRCA1 and BRCA2 mutation carriers, but on obtaining and reading the articles, our predetermined inclusion criteria were met only by 7 studies that were included in the meta-analysis [23]–[29].